Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph I/II Nivolumab in comb w/ Lenalidomide in relapsed/refractory NHL and HD

Protocol: OSU-16167

Full Title

A Phase I/II Study of the PD-1 Antibody Nivolumab in combination with Lenalidomide in relapsed/refractory Non-Hodgkin’s Lymphoma (NHL) and Hodgkin’s Disease (HD)

For More Information

See Full Trial at ClinicalTrials.gov
Email This Trial to Your Physician to Verify Eligibility
Print a Copy of This Trial
Learn More About Clinical Trial Phases
Protocol Page (Login Required)
Lymphoma Non-Hodgkin’s Lymphoma (B- & T-Cell) Hodgkin’s Lymphoma

Related News

July 21, 2017

Tips for First Time Pelotonia Riders

Every Pelotonia is an amazing, emotional and uplifting event. But there’s nothing quite like your first Pelotonia.

July 20, 2017

New Swallowing Study Aims to Help Head and Neck Cancer Patients

After head and neck cancer patients are treated, they can still face significant challenges, including difficulty with swallowing.

July 19, 2017

Study Reveals a New Mechanism of Natural Killer Cell Activation

Researchers have discovered a previously unknown mechanism that enables a certain type of immune cell to recognize and kill viral-infected cells. The findings could have important implications for...

More News
More Blog Posts